Harnessing Non-Degrading Molecular Glues to Rewire Immune Signalling & Expand Therapeutic Opportunities
1:30 pm - Thursday 28th January 2027
- Leveraging non-degrading molecular glues to induce productive protein-protein interactions, expanding the induced proximity toolkit beyond targeted protein degradation
- Reprogramming immune signalling pathways through proximity-driven modulation of transcription factors and other immunological regulators, unlocking new therapeutic opportunities in immune-mediated diseases
- Advancing orally available small-molecule therapies that deliver biologics-like effects through targeted protein interaction control, broadening the clinical potential of molecular glues
